SQZ Biotechnologies’ $60 Million Common Stock Offering

Martina Bellini
Tagged:

Latham & Watkins LLP represented SQZ Biotechnologies Company in the transaction.SQZ Biotechnologies Company (NYSE: SQZ) (SQZ), a cell therapy company developing novel treatments for multiple therapeutic…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now